{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:42:11Z","timestamp":1784634131444,"version":"3.55.0"},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Psychiatry"],"DOI":"10.4088\/jcp.25m15868","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:24:47Z","timestamp":1756905887000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy, Tolerability, and Safety of TRPC4\/5 Inhibitor BI 1358894 in Patients With Major Depressive Disorder and Inadequate Response to Antidepressants"],"prefix":"10.4088","volume":"86","author":[{"given":"Richard C.","family":"Shelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A.","family":"Pizzagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elan A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Dickschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Asafu-Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Feldbarg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd D.","family":"S\u00fcssmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2558","published-online":{"date-parts":[[2025,9,3]]},"container-title":["The Journal of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:24:47Z","timestamp":1756905887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/jcp\/efficacy-tolerability-safety-trpc4-5-inhibitor-bi-1358894-major-depressive-disorder-inadequate-response-antidepressants-phase-2-randomized-placebo-controlled-parallel-group-dose-ranging-trial\/"}},"subtitle":["A Phase 2 Randomized, Placebo-Controlled, Parallel Group, Dose-Ranging Trial"],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,3]]}},"URL":"https:\/\/doi.org\/10.4088\/jcp.25m15868","relation":{},"ISSN":["1555-2101"],"issn-type":[{"value":"1555-2101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}